Welcome to this edition of the Tecan Journal, where this time around we feature some of the usual and the not so usual applications which take advantage of Tecan’s products and services. Many of you will remember the exciting news of our partnership with the Monash Antibody Technologies Facility (MATF) in Australia and, in this issue, you can find out how the facility has developed, just weeks after its launch event. There’s news too from pharmaceutical laboratories making the most of Tecan’s exceptional throughput capabilities and flexibility to help speed up drug discovery and from cancer researchers who are replacing tedious, inefficient methods with automation.
